$BLTE stock has now fallen 15% today, according to our price data from Polygon. There has been approximately $11,647,505 of trading volume.
Here is what we see in our data on $BLTE (you can track the company live on Quiver's $BLTE stock page):
$BLTE Insider Trading Activity
$BLTE insiders have traded $BLTE stock on the open market 67 times in the past 6 months. Of those trades, 0 have been purchases and 67 have been sales.
Here’s a breakdown of recent trading of $BLTE stock by insiders over the last 6 months:
- YU-HSIN LIN (Chief Executive Officer) has made 0 purchases and 21 sales selling 100,800 shares for an estimated $19,148,375.
- HAO-YUAN CHUANG (Chief Financial Officer) has made 0 purchases and 21 sales selling 67,762 shares for an estimated $12,869,714.
- HENDRIK PETER SCHOLL (Chief Medical Officer) has made 0 purchases and 25 sales selling 22,500 shares for an estimated $3,272,799.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$BLTE Hedge Fund Activity
We have seen 58 institutional investors add shares of $BLTE stock to their portfolio, and 54 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LOGOS GLOBAL MANAGEMENT LP added 250,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $38,496,250
- NEUBERGER BERMAN GROUP LLC added 247,085 shares (+inf%) to their portfolio in Q3 2026, for an estimated $41,959,974
- MAVERICK CAPITAL LTD added 213,595 shares (+53.9%) to their portfolio in Q3 2026, for an estimated $36,272,702
- HOLOCENE ADVISORS, LP removed 195,936 shares (-78.1%) from their portfolio in Q3 2026, for an estimated $33,273,851
- CITADEL ADVISORS LLC removed 186,168 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $31,615,049
- DEERFIELD MANAGEMENT COMPANY, L.P. removed 167,199 shares (-46.8%) from their portfolio in Q3 2026, for an estimated $28,393,734
- PERCEPTIVE ADVISORS LLC removed 151,979 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $23,402,486
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$BLTE Analyst Ratings
Wall Street analysts have issued reports on $BLTE in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 11/16/2026
- Canaccord Genuity issued a "Buy" rating on 11/16/2026
- Leerink Partners issued a "Outperform" rating on 11/13/2026
- HC Wainwright & Co. issued a "Buy" rating on 10/15/2026
- Morgan Stanley issued a "Overweight" rating on 08/14/2026
- Cantor Fitzgerald issued a "Overweight" rating on 08/14/2026
To track analyst ratings and price targets for $BLTE, check out Quiver Quantitative's $BLTE forecast page.
$BLTE Price Targets
Multiple analysts have issued price targets for $BLTE recently. We have seen 6 analysts offer price targets for $BLTE in the last 6 months, with a median target of $237.5.
Here are some recent targets:
- Graig Suvannavejh from Mizuho set a target price of $230.0 on 11/16/2026
- Whitney Ijem from Canaccord Genuity set a target price of $314.0 on 11/16/2026
- Marc Goodman from Leerink Partners set a target price of $215.0 on 11/13/2026
- Yi Chen from HC Wainwright & Co. set a target price of $245.0 on 10/15/2026
- Judah Frommer from Morgan Stanley set a target price of $206.0 on 08/14/2026
- Steve Seedhouse from Cantor Fitzgerald set a target price of $270.0 on 08/14/2026
You can track data on $BLTE on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.